The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
The appointment is effective from May 01, 2023 for five years
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
Subscribe To Our Newsletter & Stay Updated
